Last10K.com

Guardion Health Sciences, Inc. (1642375) SEC Filing 10-Q Quarterly report for the period ending Friday, June 30, 2017

Guardion Health Sciences, Inc.

HISTORY TOOLS
CIK: 1642375
Document And Entity Information - shares
6 Months Ended
Jun. 30, 2017
Aug. 10, 2017
Document Information [Line Items]  
Document Type10-Q 
Amendment Flagfalse 
Document Period End DateJun. 30, 2017 
Document Fiscal Year Focus2017 
Document Fiscal Period FocusQ2 
Entity Registrant NameGuardion Health Sciences, Inc. 
Entity Central Index Key0001642375 
Current Fiscal Year End Date--12-31 
Entity Filer CategorySmaller Reporting Company 
Entity Common Stock, Shares Outstanding 25,641,551

View differences made from one quarter to another to evaluate Guardion Health Sciences, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Guardion Health Sciences, Inc..

Continue

Assess how Guardion Health Sciences, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Guardion Health Sciences, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Condensed Balance Sheets
Condensed Balance Sheets (parenthetical)
Condensed Statement Of Stockholders' Equity Deficiency
Condensed Statements Of Cash Flows
Condensed Statements Of Operations
Commitments And Contingencies
Commitments And Contingencies (details Textual)
Convertible Notes Payable
Convertible Notes Payable (details Textual)
Convertible Notes Payable (details)
Convertible Notes Payable (tables)
Inventories
Inventories (details)
Inventories (tables)
Organization And Business Operations
Organization And Business Operations (details Textual)
Promissory Notes
Promissory Notes (details Textual)
Promissory Notes (details)
Promissory Notes (tables)
Promissory Notes - Related Party
Promissory Notes - Related Party (details Textual)
Promissory Notes - Related Party (details)
Promissory Notes - Related Party (tables)
Property And Equipment, Net
Property And Equipment, Net (details Textual)
Property And Equipment, Net (details)
Property And Equipment, Net (tables)
Related Party Transactions
Related Party Transactions (details Textual)
Stockholders' Deficit
Stockholders' Deficit (details 1)
Stockholders' Deficit (details Textual)
Stockholders' Deficit (details)
Stockholders' Deficit (tables)
Subsequent Events
Subsequent Events (details Textual)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (details 1)
Summary Of Significant Accounting Policies (details Textual)
Summary Of Significant Accounting Policies (details)
Summary Of Significant Accounting Policies (policies)
Summary Of Significant Accounting Policies (tables)

Material Contracts, Statements, Certifications & more

Guardion Health Sciences, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 32.1: Section 1350 Certification
CIK: 1642375
Form Type: 10-Q Quarterly Report
Accession Number: 0001144204-17-042023
Submitted to the SEC: Thu Aug 10 2017 3:25:05 PM EST
Accepted by the SEC: Thu Aug 10 2017
Period: Friday, June 30, 2017
Industry: Pharmaceutical Preparations

External Resources:

Bookmark the Permalink:
https://last10k.com/sec-filings/1642375/0001144204-17-042023.htm